INDP
Indaptus Therapeutics Inc
2.30$
-19.3%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +198.3% | -33.7% | +161.1% | -4.7% | -65.4% | -91.6% | +2,182.4% | -30.8% | -46.8% | -50.8% | +26.9% | |
| – | +309.7% | -37.7% | +172.5% | -22.7% | -68.4% | -87.4% | +2,231.8% | -32.5% | -48.6% | -52.7% | +40.7% | |
| – | +309.8% | -30.9% | +224.8% | -26.5% | -76.3% | -82.4% | +2,289.8% | -75.4% | +38.8% | -56.7% | +47.0% | |
| – | +294.5% | -40.7% | +201.9% | -26.5% | -75.2% | -83.7% | +2,289.8% | -32.5% | -49.4% | -56.7% | +47.0% | |
| – | +198.2% | -7.8% | -33.7% | +324.9% | +71.6% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -38.7% | +12,716.0% | -53.0% | – | – | – | |
| – | -45.5% | +22.6% | +184.9% | +38.6% | +22.3% | -79.3% | +132.1% | -26.6% | -17.1% | +19.2% | +81.5% | |
| – | -29.0% | +45.8% | +199.3% | +33.2% | +9.0% | -75.8% | +128.4% | -25.4% | -19.2% | +22.3% | +81.5% | |
| – | – | – | – | – | – | -82.3% | +0.0% | -16.6% | +26.4% | -17.2% | – | |
| – | – | +87.2% | +60.9% | +53.7% | +23.1% | -95.6% | +1,591.4% | -47.7% | -41.5% | +8.0% | -37.5% | |
| – | +276.0% | -36.3% | +159.0% | -8.9% | -78.5% | -102.1% | – | -31.4% | -51.0% | -67.3% | -20.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -96.8% | +46.9% | +54.3% | +76.6% | +8.3% | +15.2% | +741.4% | +102.0% | +1.7% | +11.4% | +189.1% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.